{{Rsnum
|rsid=9974610
|Chromosome=21
|position=31646056
|Orientation=plus
|GMAF=0.08907
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 73.5 | 22.1 | 4.4
| HCB | 98.5 | 0.7 | 0.7
| JPT | 100.0 | 0.0 | 0.0
| YRI | 91.8 | 7.5 | 0.7
| ASW | 80.7 | 19.3 | 0.0
| CHB | 98.5 | 0.7 | 0.7
| CHD | 99.1 | 0.9 | 0.0
| GIH | 80.2 | 19.8 | 0.0
| LWK | 90.9 | 9.1 | 0.0
| MEX | 89.7 | 8.6 | 1.7
| MKK | 95.5 | 4.5 | 0.0
| TSI | 64.7 | 28.4 | 6.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=22608880
|Title=Allelic variations in superoxide dismutase-1 (SOD1) gene and renal and cardiovascular morbidity and mortality in type 2 diabetic subjects
}}

{{PMID Auto
|PMID=17914031
|Title=Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics study.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}